Biomx (PHGE) Stock
Early stage biotechnology company developing new treatments. Here's the price, business snapshot, and what's worth knowing about Biomx in October 2026.
BiomX Inc (PHGE) is a very small‑cap stock (market capitalisation about $15.56M) that may appeal to investors who monitor early‑stage or niche biotechnology opportunities. Small market capitalisation often means low liquidity and higher price volatility; share moves can be large on limited news. Important factors for such companies typically include R&D progress, regulatory milestones, cash runway and financing plans — any of which can materially affect value. Because information can be sparse and outcomes binary, thorough due diligence is essential: read company filings, recent presentations and trusted analyst commentary. This summary is for general educational purposes only and is not investment advice; values can fall as well as rise. Consider your tolerance for speculative, micro‑cap biotech risk and whether this fits a diversified portfolio before acting. If unsure, consult a regulated financial adviser for personalised suitability guidance.
Biomx (PHGE) Stock Forecast
Analyst price target, next 12 months
$26.00
+1313.0% vs today's $1.84
Price range over the last 12 months
Close to its 12-month low
Analysts covering Biomx have a consensus 12-month target of $26.00, above the current price of $1.84.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 11 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts highly recommend buying BIOMX Inc. stock, predicting it could rise significantly to $26.
Financial Health
BIOMX INC is generating modest revenue and cash flow, but profitability may need improvement.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Small‑Cap Dynamics
Micro‑cap status can mean big price moves on limited news; useful for active research but expect higher volatility and lower liquidity.
Binary Catalysts Matter
Clinical or regulatory announcements (if applicable) and financing rounds can sharply move the stock—though outcomes are uncertain and can be negative.
Do your research
Review filings, cash runway and management commentary; consider independent analysis and whether this risk profile suits your diversification needs.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
